Botanix Pharmaceuticals Limited

BXPHF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$13,870-$9,154-$13,171
Dep. & Amort.$0$0$110$143
Deferred Tax$0$0-$1,521-$334
Stock-Based Comp.$0$0$1,521$334
Change in WC-$31,027-$661-$4,551$1,509
Other Non-Cash-$47,558$6,403$1,521$334
Operating Cash Flow-$78,585-$8,127-$12,074-$11,184
Investing Activities
PP&E Inv.-$286-$113-$7,054-$2,922
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$763-$17,887$0$0
Investing Cash Flow-$1,050-$17,999-$7,054-$2,922
Financing Activities
Debt Repay.$27,626$0-$122-$152
Stock Issued$40,462$100,855$22,152$0
Stock Repurch.-$2,539-$5,757$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$193$0$0$0
Financing Cash Flow$65,357$95,098$22,030-$152
Forex Effect-$64$86$63-$11
Net Chg. in Cash-$14,342$69,058$2,965-$14,269
Supplemental Information
Beg. Cash$79,308$10,250$7,286$21,555
End Cash$64,967$79,308$10,250$7,286
Free Cash Flow-$79,635-$26,127-$19,128-$14,106
Botanix Pharmaceuticals Limited (BXPHF) Financial Statements & Key Stats | AlphaPilot